The need for continued education is critical in these uncertain times. Therefore, the co-directors of the Fall Clinical Dermatology Conference are excited to announce our new program: the Fall Clinical Virtual Grand Rounds (FCVGR). This new online series is designed to help maintain the educational opportunities one would have if they were able to attend grand rounds in person.

FCVGR will consist of eight weekly CME sessions on a variety of dermatological diseases and tools.

The Wednesday, April 22, 2020 session on acne and rosacea is now available on-demand.

Log in to Begin Activity

James Del Rosso, DO

Faculty

Adjunct Clinical Professor (Dermatology)
Touro University College of Osteopathic Medicine
Henderson, NV

Linda Stein Gold, MD

Faculty

Director Clinical Research
Henry Ford Health System
Detroit, MI

Upon completion of this activity, the participant should be better able to:

Correlate the clinical manifestations and selection of therapies for rosacea with underlying pathophysiologic mechanisms.
Review what's new in acne and discuss issues specific to treating acne in the COVID-19 pandemic

This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and the Foundation for Research and Education in Dermatology. The Institute is accredited by the ACCME to provide continuing medical education for physicians.

The Institute designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is partially supported by an educational grant from Almirall.

CONFLICTS OF INTEREST/DISCLOSURES

In accordance with the ACCME Standards for Commercial Support, balance, independence, objectivity, and scientific rigor are ensured in all CME activities. This requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with any commercial interest. In addition, the content of this material has been approved by an independent peer reviewer.

Disclosures are as follows:

James Del Rosso, DO

Consultant: Aclaris, Almirall, BioPharmX, Cassiopea, Celgene, Cutanea, Dermira, Encore, EPI Health, Ferndale, Foamix, Galderma, LEO LaRoche-Posay, Menlo Therapeutics, Novan, Ortho Dermatologics, Pfizer, Promius, Sanofi/Genzyme, Sonoma (Intraderm), Sol Gel, Sun Pharma, Verrica
Grant/Research Support: Abbvie, Aclaris, Almirall. Athenex, BioPharmX, Botanix, Celgene, Dermira, Foamix, Galderma, Genentech, LEO, Menlo Therapeutics, Novan, Ortho Dermatologics, Promius, Regeneron, Sanofi/Genzyme Sol Gel, Sun Pharma
Speakers’ Bureau or Honoraria: Aclaris, Almirall, Celgene, Cutane, Dermira, Encore, EPI Health, Galderma, Genetech, LEO, Ortho Dermatologics, Pfizer, Promius, Regeneron, Sanofi/Genzyme, Sol Gel, Sun Pharma, Verrica

Linda Stein Gold, MD

Consultant/Independent Contractor: Sanofi Genzyme, Regeneron, Abbvie Inc., Dermavant Sciences, Inc., LEO Pharma Inc., Valeant Pharmaceuticals International, Inc.
Grant/Research Support: Abbvie Inc., Dermavant Sciences, Inc., LEO Pharma Inc., Valeant Pharmaceuticals International, Inc.
Speakers Bureau: Sanofi Genzyme, Regeneron, LEO Pharma Inc., Pfizer Inc., Valeant Pharmaceuticals International, Inc.

Cathy Pagano (Institute for Continuing Healthcare Education) has disclosed that she has no relevant financial relationships specific to the subject matter within the past 12 months.

DISCLOSURE OF UNLABELED USE

This activity will not review off-label or investigational information.

METHOD OF PARTICIPATION

Internet

HOW TO OBTAIN CREDIT

In order to receive credit for this activity, the participant must successfully complete the evaluation and post-test.

Session 2 of 8 Managing Your Acne and Rosacea Patients in the Era of COVID-19

James Del Rosso, DO

Linda Stein Gold, MD

CONFLICTS OF INTEREST/DISCLOSURES

Session 2 of 8
Managing Your Acne and Rosacea Patients in the Era of COVID-19